AZD-7295

DB12724InvestigationalSmall molecule

AZD7295 has been investigated for the treatment of Hepatitis C.

Chemical structure of AZD-7295
Formula / weight
C32H35F3N4O5S · 644.71 g/mol (avg)
Code names
AZD7295

Resolves to

Compound
UNII102MC1467JCAS929890-64-2PubChem57339445
Structure
InChIKeyMAQDQJWCSSCURR-UHFFFAOYSA-NSMILESCCCS(=O)(=O)N1CCN(CC2=CC=C(NC(=O)C3=CC=C(C=C3)C3=CC(NC(=O)C4CC4)=CC=C3OC(F)(F)F)C=C2)CC1
Targets
P26664Genome polyprotein

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with AZD-7295, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In